Vincerx Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
IND Application filed for potential best-in-class ADC, VIP943; Phase 1 trial expected to begin Q4…
News
Get Verizon’s new +play offer for Netflix Premium, on us, with MasterClass and Super Duolingo
Mobile customers get even more streaming savings with myPlan, including Verizon’s latest exclusive bundle with…
HFR, Inc. Signs Agreement With KT to Collaborate on Private 5G Business
SEOUL, S.KOREA, Aug 7, 2023 – (ACN Newswire) – HFR, Inc. (KOSDAQ 230240), the leading…
RealPage Announces Demandx, An AI-Powered Multifamily Demand Optimization Solution
Designed to help property managers spend smarter, lease faster and price right RICHARDSON, Texas–(BUSINESS WIRE)–RealPage,…
Oragenics, Inc. Announces Private Placement
TAMPA, Fla.–(BUSINESS WIRE)–Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), biotech company dedicated to…
Longevity Biotech Companies GERO and FOXO Technologies™ to Embark on Joint Initiative on Artificial Intelligence and Epigenetic Data to Discover Signatures of Human Health Trajectories
PALO ALTO, Calif. & MINNEAPOLIS, Minn.–(BUSINESS WIRE)–GERO, a leading AI-driven biotechnology company focused on aging…
MaxLinear announces production availability of Panther III storage accelerator OCP adapter card
High-performance storage accelerator provides 200Gbps throughput and is scalable to 3.2Tbps CARLSBAD, Calif.–(BUSINESS WIRE)–#connectivity–MaxLinear, Inc….
GT Biopharma Reports Second Quarter 2023 Financial Results
Cash of approximately $18.0 million as of June 30, 2023, provides ample runway to fund…
GT Biopharma Reports Second Quarter 2023 Financial Results
Cash of approximately $18.0 million as of June 30, 2023, provides ample runway to fund…
GRI Bio Presents Encouraging Preclinical Data Indicating Oral Administration of GRI-0803 Inhibited Lupus Nephritis and Significantly Improved Overall Survival in Animal Models
Data presented at The Autoimmunity Conference hosted by the Federation of American Societies for Experimental…
GRI Bio Presents Encouraging Preclinical Data Indicating Oral Administration of GRI-0803 Inhibited Lupus Nephritis and Significantly Improved Overall Survival in Animal Models
Data presented at The Autoimmunity Conference hosted by the Federation of American Societies for Experimental…
IO Biotech, Inc. Announces $75 Million Private Placement Financing
Offering includes participation from both new and existing healthcare-dedicated investors Proceeds extend the company’s cash…
IO Biotech, Inc. Announces $75 Million Private Placement Financing
Offering includes participation from both new and existing healthcare-dedicated investors Proceeds extend the company’s cash…
Preclinical Data Showing Strong Immunogenicity and Protection with IMUNON’s PlaCCine DNA-Based Vaccines Modality Available Online on bioRxiv
LAWRENCEVILLE, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development…
Preclinical Data Showing Strong Immunogenicity and Protection with IMUNON’s PlaCCine DNA-Based Vaccines Modality Available Online on bioRxiv
LAWRENCEVILLE, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development…
ABVC Corporate Update and CEO’s Letter to Shareholders
FREMONT, CA, Aug. 07, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC)…
ABVC Corporate Update and CEO’s Letter to Shareholders
FREMONT, CA, Aug. 07, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC)…
Lisata Therapeutics to Report Second Quarter 2023 Financial Results on Monday, August 14 After Market Trading and to Host Conference Call on Tuesday, August 15 at 8:30 a.m. Eastern Time
BASKING RIDGE, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”…
Lisata Therapeutics to Report Second Quarter 2023 Financial Results on Monday, August 14 After Market Trading and to Host Conference Call on Tuesday, August 15 at 8:30 a.m. Eastern Time
BASKING RIDGE, N.J., Aug. 07, 2023 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”…
Dyadic Announces Continued Progress Towards Commercialization of Animal-Free Recombinant Serum Albumin
JUPITER, Fla., Aug. 07, 2023 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”,…